BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Diagnosis
115 results:

  • 1. Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
    Judd S; Revon-Riviere G; Grover SA; Deyell RJ; Vanan MI; Lewis VA; Pecheux L; Zorzi AP; Goudie C; Santiago R; Tran TH; Abbott LS; Brossard J; Moorehead P; Alvi S; Portwine C; Denburg A; Whitlock JA; Cohen-Gogo S; Morgenstern DA
    Cancer Med; 2024 Feb; 13(3):e7033. PubMed ID: 38400668
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The obeticholic acid can positively regulate the cancerous behavior of MCF7 breast cancer cell line.
    Rahmani R; Eivazi N; Emamgholipour S; Aminian M; Jalilian A; Paknejad M
    Mol Biol Rep; 2024 Feb; 51(1):250. PubMed ID: 38302816
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma.
    Owens E; Harris L; Harris A; Yoshimoto J; Burnett R; Avery A
    BMC Cancer; 2024 Jan; 24(1):18. PubMed ID: 38166662
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Primary central nervous system marginal zone lymphoma.
    Flospergher E; Marino F; Calimeri T; Cangi MG; Ferreri AJM; Ponzoni M; Bongiovanni L
    Br J Haematol; 2024 Jan; 204(1):31-44. PubMed ID: 38054330
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic Profiling of Primary Diffuse Large B-Cell lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
    Agostinelli C; Morandi L; Righi S; Cirillo L; Iommi M; Tonon C; Mazzatenta D; Zoli M; Rossi M; Bagnato G; Broccoli A; Lodi R; Zinzani PL; Sabattini E; Giannini C; Asioli S
    Mod Pathol; 2023 Dec; 36(12):100323. PubMed ID: 37678673
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Disparities in Time to diagnosis Among Patients With Multiple Myeloma.
    Lin OM; Paine D; Gramling E; Menon M
    Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e379-e385. PubMed ID: 37612207
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma.
    Elkady MA; Yehia AM; Elsakka EGE; Abulsoud AI; Abdelmaksoud NM; Elshafei A; Elkhawaga SY; Ismail A; Mokhtar MM; El-Mahdy HA; Hegazy M; Elballal MS; Mohammed OA; El-Husseiny HM; Midan HM; El-Dakroury WA; Zewail MB; Abdel Mageed SS; Doghish AS
    Pathol Res Pract; 2023 Aug; 248():154704. PubMed ID: 37499518
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.
    Gao F; Liu H; Meng X; Liu J; Wang J; Yu J; Liu X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Golchehre Z; Chavoshzadeh Z; He J; Zhang H; Wang X
    Br J Haematol; 2023 Sep; 202(6):1151-1164. PubMed ID: 37455019
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: The Central and Western China AIDS lymphoma League 001 study (CALL-001 study).
    Wang C; Wu Y; Liu J; Min H; Huang Y; Wei G; Zhang W; Wang M; Tang X; Zhou H; Chen Y; Liu Y
    Front Immunol; 2023; 14():1153790. PubMed ID: 37063928
    [TBL] [Abstract] [Full Text] [Related]  

  • 10.
    Wu X; Li Y; Zhang W; Zhang J; Chen B; Ge Z
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552804
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genes associated with diagnosis and prognosis of Burkitt lymphoma.
    Doughan A; Salifu SP
    IET Syst Biol; 2022 Dec; 16(6):220-229. PubMed ID: 36354023
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Value of the prognostic nutritional index (PNI) in patients with newly diagnosed, CD5-positive diffuse large B-cell lymphoma: A multicenter retrospective study of the Huaihai lymphoma Working Group.
    Ma S; Zhang B; Lu T; Li D; Li T; Shen Z; He C; Wang Y; Li B; Zhang H; Gu W; Wang C; Ye J; Zhu T; Miao Y; Wang L; Huang S; Liu Q; Sang W;
    Cancer; 2022 Oct; 128(19):3487-3494. PubMed ID: 35932292
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry.
    Gong Y; Zhou L; Ding L; Zhao J; Wang Z; Ren G; Zhang J; Mao Z; Zhou R
    Medicine (Baltimore); 2022 Jun; 101(24):e29312. PubMed ID: 35713434
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR-33a/b to disinhibit PD-L1.
    Dong L; Huang J; Gao X; Du J; Wang Y; Zhao L
    Cancer Sci; 2022 Aug; 113(8):2888-2903. PubMed ID: 35579082
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. miRNAs in Lymphocytic Leukaemias-The miRror of Drug Resistance.
    Sbirkov Y; Vergov B; Mehterov N; Sarafian V
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563051
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identification of Serum miRNAs as Effective Diagnostic Biomarkers for Distinguishing Primary Central Nervous System lymphoma from Glioma.
    Si PP; Zhou XH; Qu ZZ
    J Immunol Res; 2022; 2022():5052609. PubMed ID: 35497882
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The utility of cerebrospinal fluid-derived cell-free DNA in molecular diagnostics for the
    Chen WL; Pao E; Owens J; Glass I; Pritchard C; Shirts BH; Lockwood C; Mirzaa GM
    Cold Spring Harb Mol Case Stud; 2022 Apr; 8(3):. PubMed ID: 35483878
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Novel TENM3-ALK fusion is an alternate mechanism for ALK activation in neuroblastoma.
    Hiwatari M; Seki M; Matsuno R; Yoshida K; Nagasawa T; Sato-Otsubo A; Yamamoto S; Kato M; Watanabe K; Sekiguchi M; Miyano S; Ogawa S; Takita J
    Oncogene; 2022 May; 41(20):2789-2797. PubMed ID: 35411036
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell lymphoma.
    Shen Y; Wang L; Ou J; Wang B; Cen X
    Int J Med Sci; 2022; 19(2):225-232. PubMed ID: 35165508
    [No Abstract]    [Full Text] [Related]  

  • 20. Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma-a retrospective cohort study.
    Kagan KBT; Guz D; Buchrits S; Gurion R; Vaxman I; Priss M; Groshar D; Catalano OA; Sherban A; Raanani P; Gafter-Gvili A; Bernstine H
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2290-2299. PubMed ID: 35079846
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.